BIVIX
Price
$17.49
Change
+$0.26 (+1.51%)
Updated
Feb 21 closing price
Net Assets
1.11B
QLENX
Price
$16.55
Change
-$0.13 (-0.78%)
Updated
Feb 21 closing price
Net Assets
2.85B
Ad is loading...

BIVIX vs QLENX

Header iconBIVIX vs QLENX Comparison
Open Charts BIVIX vs QLENXBanner chart's image
Invenomic Institutional
Price$17.49
Change+$0.26 (+1.51%)
VolumeN/A
Net Assets1.11B
AQR Long-Short Equity N
Price$16.55
Change-$0.13 (-0.78%)
VolumeN/A
Net Assets2.85B
BIVIX vs QLENX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIVIX vs. QLENX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVIX is a Buy and QLENX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 2.85B vs. BIVIX (1.11B). QLENX pays higher dividends than BIVIX: QLENX (18.52) vs BIVIX (2.62). BIVIX was incepted earlier than QLENX: BIVIX (8 years) vs QLENX (12 years). BIVIX is a more actively managed with annual turnover of: 140.00 vs. QLENX (0.00). QLENX has a lower initial minimum investment than BIVIX: QLENX (2500) vs BIVIX (50000). QLENX annual gain was more profitable for investors over the last year : 28.94 vs. BIVIX (1.15). QLENX return over 5 years is better than : 119.29 vs. BIVIX (77.95).
BIVIXQLENXBIVIX / QLENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years12 years-
Gain YTD1.0406.15817%
Front LoadN/AN/A-
Min. Initial Investment5000025002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B2.85B39%
Annual Yield % from dividends2.6218.5214%
Returns for 1 year1.1528.944%
Returns for 3 years-14.4670.77-20%
Returns for 5 years77.95119.2965%
Returns for 10 yearsN/A129.41-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRI13.810.01
+0.07%
Everi Holdings
YETI36.83-0.08
-0.22%
YETI Holdings
GNFT3.83-0.09
-2.30%
Genfit SA
CTXR1.80-0.05
-2.70%
Citius Pharmaceuticals Inc
AER101.67-4.11
-3.89%
Aercap Holdings NV